DBV Technologies increases expertise in peanut allergy diagnosis and treatment with SAB appointments

DBV Technologies Expands Scientific Advisory Board with Appointment of Food and Paediatric Allergy Specialists

21-Oct-2009 - France

DBV Technologies announced the expansion of its Scientific Advisory Board with the appointments of paediatric allergy and paediatric food allergy specialists Professor Gideon Lack and Associate Professor Philippe Eigenmann.

In joining DBV Technologies’ Scientific Advisory Board, Professors Lack and Eigenmann provide the Company with access to their expertise in paediatric food allergy diagnosis and treatment. These SAB appointments are of strategic importance to DBV Technologies, as the Company works towards the initiation of its first US Phase I clinical trial for peanut allergy.

Professor Lack is Head of the Children’s Allergy service at Guy’s and St Thomas’ NHS Foundation Trust and a Professor of Paediatric Allergy at King’s College, London, United Kingdom. Professor Lack’s current research is focused on developing novel immunomodulatory treatments for food allergies and new strategies to prevent the development of allergies and asthma in children.

Professor Eigenmann is an Associate Professor at the Department of Infants and Adolescents at the Hospital cantonal Universitaire Geneve (HUG), Geneva, Switzerland,specialising in paediatric allergy diagnosis and treatment. His current research is focused on the pathogenesis of food allergy with regard to sensitization procedures in the bowel, as well as investigating therapeutic food allergy treatment strategies using mouse models.

https://www.bionity.com/en/news/108208/dbv-technologies-increases-expertise-in-peanut-allergy-diagnosis-and-treatment-with-sab-appointments.html